Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The primary hypothesis constitutes that the fish-oil preparation (Omegaven) is superior to
the preparation based on Soja-oil (Lipovenös)to reduce signs and symptoms in patients with
active rheumatoid arthritis.